Jacksonville, Fla.-based Baptist Health and the University of Texas MD Anderson Cancer Center are planning to create a joint cancer care program in 2015 that will serve north Florida.
Pharmaceutical giant Genentech has come under a maelstrom of criticism from hospitals for its decision to change its distribution methods for three widely used cancer drugs, and now the nation's largest not-for-profit health system is responding with a bold message.
The related issues of healthcare costs and the appropriateness of molecular and genetic testing will be considered by pathologists attending the annual meeting this week of the College of American Pathologists.
As one fight between Pittsburgh's two healthcare giants simmers, another has begun. Insurer Highmark filed a fresh lawsuit against UPMC alleging the hospital system has charged exorbitant prices for cancer drugs and services. Highmark said UPMC's billing strategy has resulted in $300 million in...
City of Hope, the not-for-profit comprehensive cancer center, reported that smaller gifts and an increase in its expenses led to a tighter operating margin in the first nine months of its fiscal 2014, which ends Sept. 30.
Dr. Patrick Soon-Shiong is one of the most well-known surgeons in healthcare. He's worth billions of dollars, thanks to several medical and pharmaceutical breakthroughs. He's also a minority owner of the NBA's Los Angeles Lakers. So why has he decided to take a job with Renton, Wash.-based...
Game theory is popular among poker players, economists and politicians. Now, oncology researchers are employing game theory to look for new ways to combat tumors.
About 1 of every 370 women who underwent a minimally invasive hysterectomy using morcellation was found to have uterine cancer, a finding that is consistent with data that the Food and Drug Administration put out this month.
Dr. Harold Paz, CEO of Penn State Milton S. Hershey (Pa.) Medical Center, will step down and become chief medical officer of health insurer Aetna, effective July 28. He will replace Dr. Lonny Reisman, who left Aetna in April.
Two new studies are raising concerns about management of early stage prostate cancer and treatment.
Two new studies are raising concerns about management of early-stage prostate cancer treatments in U.S. men.
Keck Medicine of USC completed its acquisition of Orange Coast Oncology Hematology Medical Associates in a move intended to extend the academic medical center's comprehensive cancer care to more convenient local settings.